Clinical Trial Update: Herceptin and GM-CSF for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This update reports the completion and posting of results for a Phase 2 trial of Herceptin (trastuzumab) with GM-CSF in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-04-15